12345678910111213141516171819202122232425262728
A
PPLE
’
S
R
ESPONSE TO
Q
UALCOMM
’
S
M
OTION ON
C
URATIVE
I
NSTRUCTION
C
ASE
N
O
. 3:17-cv-01375-DMS-MDD
1
I.
INTRODUCTION
Arjuna Siva
1
appeared at trial yesterday and truthfully and fully explained how he developed and communicated to Qualcomm the idea that Qualcomm claims is the “solution” covered by the ’949 patent—on which Mr. Siva is not named as an inventor. That is exactly the testimony that Apple expected Mr. Siva to provide because he had previously testified to those facts under oath at his deposition. Now that Mr. Siva has testified, the issue of a curative instruction about his unavailability is moot. Suggestions by Qualcomm and Matt Warren
2
that Apple’s concerns were baseless ignores the undisputed chronology and facts. More importantly, it ignores what Mr. Warren said to Apple in the less than 24 hours he served as Mr. Siva’s counsel. In a real sense, Qualcomm is suggesting that the Court punish the victim or that the victim apologize. As set forth below, the record unequivocally demonstrates that Apple had good reason for its concerns and acted responsibly in raising those concerns with the Court. Indeed, for many months, Mr. Siva was planning to voluntarily testify at trial:
February 15, 2018: Mr. Siva is deposed in the International Trade Commission (ITC) litigation and represented by WilmerHale. Mr. Siva testified based on Qualcomm’s own description of the “solution” provided by the ’949 patent that he believed the idea was his.
April 25, 2018: After Mr. Siva testified in his ITC deposition, Qualcomm withdrew the ’949 patent from that case.
October 30, 2018: WilmerHale counsel speaks with Mr. Siva about this trial.
November 29, 2018: WilmerHale counsel meets with Mr. Siva for trial preparation.
February 21, 2019: WilmerHale counsel meets with Mr. Siva for trial
1
Mr. Sivasithambaresan shortens his last name to Siva.
2
Letter to the Court from David H. Kramer on behalf of Matt Warren, Dkt. 669.
Case 3:17-cv-01375-DMS-MDD Document 677 Filed 03/12/19 PageID.38491 Page 2 of 16